[ Price : $8.95]
Teva petitions FDA asking it not to approve any ANDAs that reference Treanda (bendamustine hydrochloride) until its orphan exclusi...[ Price : $8.95]
FDA posts a guidance on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment that provides reco...[ Price : $8.95]
FDA grants Daiichi Sankyo and Plexxikon a breakthrough therapy designation for their investigational oral CSF-1R inhibitor pexidar...[ Price : $8.95]
Federal Register Notice: The Office of Management and Budget approves a collection of information on the impact of ad exposure fre...[ Price : $8.95]
Federal Register Notice: The Office of Management and Budget approves a collection of information on a survey on the physical char...[ Price : $8.95]
Federal Register Notice: FDA determines that 13 ANDAs were not withdrawn from sale for reasons of safety or effectiveness.[ Price : $8.95]
Federal Register Notice: FDA announces a stay of portions of its final guidance: Investigational New Drug Applications Determinin...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 12/2: Clinical Trials Assessing Safety and Efficacy in Diverse Populations....